A.A. Gritskevich, T.P. Byteman, D.M. Monakov, I.G. Rusakov, S.V. Mishugin
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
|
№11 / 2023
|
T.N. Trofimtseva, S.K. Yarovoy, A.A. Gritskevich
Prevalence of chronic kidney disease among cancer patients
|
№11 / 2023
|
N.N. Buevich (1), S.A. Protsenko (1), A.K. Nosov (1), S.A. Reva (1, 2), A.S. Artemyeva (1), M.V. Berkut (1)
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer
|
№7 / 2019
|
I.S. Varlamov (1, 2), S.A. Varlamov (1), A.F. Lazarev (1, 2)
PROSTATE-SPECIFIC ANTIGEN AS A CRITERION OF PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY
|
№17 / 2016
|
A.O. Vasiliev, A.V. Govorov, E.A. Prilepskaya, E.G. Maltsev, D.Yu. Pushkar
SALVAGE ROBOT-ASSISTED RADICAL PROSTATECTOMY AFTER FOCAL PROSTATE CRYOABLATION
|
№s1-16 / 2016
|
P.I. Rasner (1), B.M. Brodetsky (1), D.Yu. Pushkar (1)
MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF PROSTATE CANCER
|
№s1-16 / 2016
|
A.A. Kostin (1), M.I. Andrjuhin (1), S.A. Pul'bere (1), P.I. Motin (2), N.K. Agaev (2)
THE STUDY OF GROWTH FACTORS IN VARIOUS PROSTATIC DISEASES
|
№12 / 2015
|
S.V. Mishugin, A.A. Mordovin, A.A. Gritskevich, I.G. Rusakov
EXPERIENCE OF THE USE OF OCTREOTIDE IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER
|
№8 / 2015
|
E.B. Shakhnovich (1), А.А. Kopyltsov (1), N.O. Sultanova (1), O.B. Kerbikov (2)
PROSTATE CANCER: POTENTIALS FOR THE APPLICATION OF LUTEINIZING HORMONE-RELEASING HORMONE AGONISTS
|
№18 / 2014
|
V.A. Tchernyaev
HORMONE THERAPY OF PROSTATE CANCER
|
№8 / 2013
|
I.G.Rusakov, A.A.Kosov, S. V. Mishugin
Place Of Drug Therapy In The Prevention And Treatment Of Bone Complications Of Prostate Cancer
|
№18 / 2012
|
D. Sokov, I.G. Rusakov
Assessment Of Effect Of Various Schemes Of Hormonal Therapy On Testosterone Level And Quality Of Life Of Patients With Locally Advanced Or Generalized Prostate Cancer
|
№17 / 2011
|